Advertisement

Investment in digital health – the impact of global legal developments

While the breadth of digital health products available to the market continues to expand, Hamza Drabu, partner and head of health at DAC Beachcroft,...

InLaw: Medtech regulatory challenges posed by diverging UK and EU regulations

Medtech innovators face an increasingly complex regulatory framework following Brexit. Ian Manners, a regulatory partner at UK law firm Ashfords, looks at the challenges...

InLaw: Cannabisgesetz – a step forward

Germany’s landmark cannabis law marks a significant step forward for the European cannabis landscape, argues Thomas Schatton, CEO of Four 20 Pharma, a Curaleaf...

InLaw: the start of the EPR convergence journey

EPR systems have the potential to bring tremendous benefits to our health and social care systems and indeed patients, says Kay Chand, partner at...

InLaw: Lincoln Tsang at Ropes & Gray talks to Investors in Healthcare about plans...

In September 2023, the European Medicines Agency (EMA) will reinstate Policy 0070 meaning that clinical data submitted for the purposes of regulatory approval will...

Kilburn & Strode investigates the role of patents in psychedelics

An increasing number of clinical studies show promising results for the use of psychedelic therapies in the treatment of various mental health conditions. Research...

The importance of mental health support during civil claims

To mark mental health awareness week, Investors in Healthcare asked consultant psychiatrist and medico-legal expert Dr Nick Cooling and Zahra Awaiz-Bilal, senior associate in...

InLaw: Supporting Singapore’s healthcare transformations

Singapore’s Ministry of Health has confirmed its intention to table the Health Information Bill in the second half of 2023. Andy Leck and Ren...

Browne Jacobson’s Charlotte Harpin looks at the risks and opportunities arising from the use...

Recent developments in AI, including DALL-E 2 and ChatGPT, have reignited widespread excitement about the potential of AI across all aspects of our lives....

In Law: Buddle Findlay considers upcoming major change for medical device businesses in New...

New legislation is before the select committee which could significantly change the regulatory landscape for businesses involved in the medical device industry (including manufacturers,...
Advertisement